Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 37,697 | 48,850 | 45,428 | 48,482 | 41,285 |
| Operating Income | -37,697 | -48,850 | -45,428 | -48,482 | -41,285 |
| Interest Expense | 828 | 985 | 633 | 835 | 539 |
| Other Income | 671 | 1,349 | 1,589 | 2,302 | 2,434 |
| Pre-tax Income | -37,854 | -48,486 | -44,472 | -47,015 | -39,390 |
| Net Income Continuous | -37,854 | -48,486 | -44,472 | -47,015 | -39,390 |
| Net Income | $-37,854 | $-48,486 | $-44,472 | $-47,015 | $-39,390 |
| EPS Basic Total Ops | -0.47 | -0.60 | -0.57 | -0.59 | -0.50 |
| EPS Basic Continuous Ops | -0.47 | -0.60 | -0.56 | -0.59 | -0.50 |
| EPS Diluted Total Ops | -0.47 | -0.60 | -0.57 | -0.59 | -0.50 |
| EPS Diluted Continuous Ops | -0.47 | -0.60 | -0.56 | -0.59 | -0.50 |
| EBITDA(a) | $-35,921 | $-47,061 | $-44,727 | $-47,634 | $-40,500 |